Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6747105

Bis-Schiff base ligand-containing mono-metallocene olefin polymerization catalyst, its pre

East China University of Science and Technology · Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6713478

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696459

Steroid receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693103

1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680176

Identification of candidate ligands which modulate antigen presenting cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6670387

Thrombopoietin mimetics

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6667313

8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6667036

Methods of treatment using antibodies to P-selectin glycoprotein ligand

The Board of Regents of the University of Oklahoma · Granted Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6664374

Polypeptides comprising IL-6 ligand-binding receptor domains

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6645484

Method of blocking blood vessel growth using tie-2 ligand 2

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6627415

TIE-2 ligands, methods of making and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610696

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608068

Indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6602683

Biologically active Eph family ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6599921

Non-steroidal estrogen receptor ligands

Nanodesign Inc. · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593359

Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593493

RXR modulators with improved pharmacologic profile

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593308

Targeted drug delivery with a hyaluronan ligand

The Regents of the University of California · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6590090

Fas ligand-like protein, its production and use

Takeda Chemical Industries Ltd. · Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583145

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576676

Means for the modulation of processes mediated by retinold receptors and compounds useful

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566358

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566372

Bicyclic androgen and progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6555367

Complex of biotinylated viral vector and ligand for targeted gene delivery

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired